EQS-News: Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success
Despite a persistently challenging environment, the company succeeded in significantly increasing all key earnings figures and at EUR 540.6 million (2022: EUR 542.2 million) maintaining Group sales almost at the previous year’s record level.
- Despite a persistently challenging environment, the company succeeded in significantly increasing all key earnings figures and at EUR 540.6 million (2022: EUR 542.2 million) maintaining Group sales almost at the previous year’s record level.
- Primarily due to the increasing weight of the higher-margin growth segment Specialty Chemicals, Alzchem succeeded in significantly increasing Group EBITDA by 32.4% to EUR 81.4 million in the fiscal year 2023 (previous year: EUR 61.4 million).
- Operating cash flow also developed strongly in the fiscal year 2023, which was once again clearly positive at EUR 72.7 million (2022: EUR -4.2 million).
- Thanks to them, the Alzchem Group remains on course for success,” explains Andreas Lösler, CFO of Alzchem Group AG.